We educate and advise leadership and staff of CMS, HHS, and AHRQ on the public payer reimbursement, coverage, and coding issues of existing products and products in the laboratory and the pipeline for our clients. We supplement our education and advocacy with strong intelligence gathering, a solid knowledge of agency policies and practices, personal relationships and a course of action, strategies and tactics derived from singularly focused experience.

We advise clients planning significant new initiatives in the regulatory arena, and provide independent expert opinion on policy and business issues in health care, helping to explore the ramifications of various public and reimbursement policy options. Importantly, we provide options which go beyond traditional formulaic approaches.

We assist clients in identifying and executing key business opportunities and strategic partnerships.

We work with the investment community to identify potentially material changes in the regulatory and reimbursement environments faced by health care companies; and assess problems and opportunities in potential health care investments before the beginning of active due diligence.

We counsel clients on business to business or business to government procurement issues.  Whether purchasing or selling a business, defending against alleged state and federal violations, or moving to add value to the organization our approach is to increase our client’s visibility and credibility by building trust and personal relationships with the right decision-makers.  During the bid process, we consult with our clients to increase the probability of securing new business.